Fund HoldingsTAKEDA PHARMACEUTICAL CO LTD

Total Portfolio Value
$232.31M
Total Bought
$0
Total Sold
$30.93M
Net Transaction
-$30.93M
Filing Period:
Securities
SharesValue ($K)
Q1 2024
Q2 2024
Change
Q1 2024
Q2 2024
Weight (%)
Change
Denali Therapeutics Inc.(DNLI)4,214,5594,214,559086,48397,86242.13%+11,379
Akili, Inc.738,819738,81902143210.14%+107
Turnstone Biologics Corp.895,824895,82402,3472,3471.01%0
STANDARD BIOTOOLS INC.16,51516,515045290.01%-16
Xilio Therapeutics, Inc.1,475,1211,475,12101,5931,3980.60%-195
Rani Therapeutics Holdings, Inc.338,679215,172-123,5071,0538180.35%-236
Aerovate Therapeutics, Inc.13,5800-13,5804020-402
American Well Corp1,554,6691,554,66901,2605050.22%-755
Day One Biopharmaceuticals, Inc.
COM
85,8400-85,8401,4180-1,418
Wave Life Sciences Ltd.(WVE)1,346,8921,346,89208,3106,7212.89%-1,589
Equillium, Inc.1,824,9771,824,97704,2161,2590.54%-2,956
Shattuck Labs, Inc.1,501,061515,619-985,44213,4191,9900.86%-11,429
HilleVax, Inc.6,724,0006,724,0000111,82197,22941.85%-14,591
Ovid Therapeutics Inc.7,531,9967,531,996022,9735,7922.49%-17,180
Phathom Pharmaceuticals, Inc.3,153,2171,557,063-1,596,15433,48716,0386.90%-17,449
Page 1 of 1